Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Stomatitis 3 Head and Neck Neoplasms 3 Fatigue 3 Colorectal Neoplasms 3 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Ulcer 1 Trauma, Nervous System 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Schwannomatosis 1 Rectal Neoplasms 1 Psoriasis 1 Pleural Effusion, Malignant 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Non-functioning Pituitary Adenoma 1 Neurofibromatosis 1 1 Neurilemmoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Mesothelioma 1 Malignant Neoplasm of Colorectum 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1

Interventions

Carboplatin 2 Bevacizumab 2 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 liposomal doxorubicin 1 Saline Solution 1 Paclitaxel 1 Neoadjuvant Therapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Ovarian Cancer × Saline Solution × Clear all

NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡